We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

163 hedge funds and large institutions have $633M invested in Natus Medical Inc in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 51 increasing their positions, 61 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 17

21% more capital invested

Capital invested by funds: $525M → $633M (+$108M)

3% more funds holding

Funds holding: 159163 (+4)

16% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 61

76% less call options, than puts

Call options by funds: $433K | Put options by funds: $1.82M

Holders
163
Holders Change
+4
Holders Change %
+2.52%
% of All Funds
2.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
51
Reduced
61
Closed
17
Calls
$433K
Puts
$1.82M
Net Calls
-$1.39M
Net Calls Change
-$1.28M
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$5.43M -$81.8K -4,179 -2%
Ameriprise
27
Ameriprise
Minnesota
$5.19M +$217K +11,056 +4%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$4.61M -$326K -16,667 -7%
Millennium Management
29
Millennium Management
New York
$4.43M -$930K -47,494 -18%
Nordea Investment Management
30
Nordea Investment Management
Sweden
$4.09M +$185K +9,434 +5%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$4.07M +$79.2K +4,042 +2%
SCM
32
Sio Capital Management
New York
$3.74M +$1.63M +83,008 +80%
LIP
33
Liontrust Investment Partners
United Kingdom
$3.59M +$3.5M +178,940 New
CIM
34
Confluence Investment Management
Missouri
$3.07M +$52.3K +2,669 +2%
Morgan Stanley
35
Morgan Stanley
New York
$2.88M +$1.11M +56,907 +65%
Bank of America
36
Bank of America
North Carolina
$2.67M -$265K -13,551 -9%
Deutsche Bank
37
Deutsche Bank
Germany
$2.66M -$704K -35,953 -21%
PPA
38
Parametric Portfolio Associates
Washington
$2.53M +$589K +30,064 +31%
Acadian Asset Management
39
Acadian Asset Management
Massachusetts
$2.48M +$444K +22,666 +22%
RCM
40
Rutabaga Capital Management
Massachusetts
$2.42M -$942K -48,112 -29%
State of New Jersey Common Pension Fund D
41
State of New Jersey Common Pension Fund D
New Jersey
$2.38M -$170K -8,700 -7%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$2.32M +$219K +11,194 +11%
BCC
43
Bridge City Capital
Oregon
$2.24M -$22.8K -1,165 -1%
RA
44
Royce & Associates
New York
$2.13M +$26.1K +1,335 +1%
Legal & General Group
45
Legal & General Group
United Kingdom
$2.08M
MSL
46
Mackay Shields LLC
New York
$1.88M +$971K +49,600 +112%
ECM
47
ExodusPoint Capital Management
New York
$1.87M +$1.54M +78,782 +544%
CIC
48
Cornercap Investment Counsel
Georgia
$1.83M +$1.09M +55,505 New
Lord, Abbett & Co
49
Lord, Abbett & Co
New Jersey
$1.75M -$6.55M -334,491 -79%
Man Group
50
Man Group
United Kingdom
$1.72M +$379K +19,339 +29%

NTUS Hedge Fund Activity: Q4 2020 in Review

163 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2020, worth a combined $633M — up 21% from $525M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NTUS positions and 17 closed out — a net gain of 5 holders — while 51 added to existing stakes and 61 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $7.37M. The largest seller was Lord, Abbett & Co, cutting an estimated $6.55M.

  • 163 institutional investors held Natus Medical Inc (NTUS) as of Q4 2020, up from 159 in Q3 2020.
  • Funds reported $633M of Natus Medical Inc stock for Q4 2020, up 21% quarter-over-quarter.
  • 22 funds opened new Natus Medical Inc positions in Q4 2020 and 17 closed out, a net change of +5 holders.
  • The largest Natus Medical Inc buyer in Q4 2020 was Janus Henderson Group, an estimated $7.37M added.
  • The largest Natus Medical Inc seller in Q4 2020 was Lord, Abbett & Co, an estimated $6.55M sold.

Based on aggregated 13F filings for Q4 2020.